11 ms·
Cystic fibrosis treatment wins Breakthrough Prize
- Blueskytech 3y agoI have a friend who has been saved by this and I have two funny points. CF makes you not process food correctly so you can eat a ton of food and not gain weight. After taking this medicine he was upset because his body started processing food correctly and he put on a bunch of weight initially. This really is a life saving cure for most general genetic versions of CF but he also remarked that it’s great they found a cure now because it’s basically a white people disease and the amount of funding it got for a cure was likely going to come under scrutiny.
- spondylosaurus 3y agoRe."white people disease," I thought this was a neat excerpt from later in the article (about Parkinson's, to be fair, not CF): > Njideka Okubadejo, a neurologist at the University of Lagos in Nigeria, welcomes the award announcement. Okubadejo, Singleton — who leads the Global Parkinson’s Genetics Program — and others have identified a new genetic risk factor for Parkinson’s disease in the GBA1 gene in people with African ancestry that is rarely seen in those of European descent7. “The next step is to find a biological mechanism by which the gene causes the disease,” Okubadejo says. “Then you can build upon that to reduce the likelihood of the disease occurring.” The distribution of random genes among ethnic subgroups is always an interesting glimpse into the situational tradeoffs that certain genes bring. Like how the gene that causes sickle cell anemia is really good for malaria resistance... but it also gives you sickle cell anemia. Which might actually be a decent tradeoff when malaria is a constant threat, so you can imagine why it's prevalent in areas where malaria-carrying mosquitos flourish. Or you hear about different HLA subtypes where like, one variation offers some kind of useful trait or immunity, but it also brings an increased risk of skin cancer, but the people who carry that gene generally lived in an area without much sun and so it was still a net advantage. Until modern times, when those people have descendants across the globe... Also, very glad to hear your friend's doing well :)
- pcchristie 3y agoAnother interesting link is that between mental health issues (schizophrenia, bipolar) and "elite" creativity and the risk of losing the latter if we can ever gene edit the former out of our genome. Siddhartha Mukherjee talks about this in The Gene.
- trollian 3y agoWe were just talking about Kurt Cobain's death from suicide with my daughter with CF. We'll take the meds thanks.
- samus 3y agoFortunately, it seems that there is a huge set of genes that affect intelligence, which hopefully makes it impossible for the forseeable future to develop a gene-therapy for them. Diseases like cystic fibrosis are low-hanging fruits compared to that.
- trollian 3y agoThere's a theory that having a single CF mutation can help combat the effects of cholera.
- paulpauper 3y agowhy can't a weight loss treatment be created harnessing a similar effect . dial down the pancreases so food does not digest as well
- tux3 3y agoMost weight loss treatments have terrible side-effects. GLP-1 is working pretty well as a target now, but all the other ideas didn't turn out so simple after all, and there were a lot of ideas for weight loss drugs
- paulpauper 3y agoso does obesity have bad side effects. we need more answers. GLP -1 is a good start
- Scoundreller 3y agoIn my opinion orlistat (blocks fat absorption) isn't that bad if you actually follow the suggested low-fat diet. But if you're hoping to counteract a pint of ice cream, it's going to work tooooo well. The Public Relations was a nightmare... never stood a chance. The jokes were too good.
- arthur2e5 3y agoAcarbose blocks starch (and sucrose, to some extent) absorption. Instead of oily poop you get dry smelly gas that hopefully goes down over time. Starch & sucrose is not as big a part of American caloric intake as fat, but it can still help cut some of that out. (Just sucrose. HFCS has glucose and fructose, which means sucrase doesn't need to work. Not a meaningful difference in most people considering how fast sucrase works, but when you block sucrase...)
- ramraj07 3y agoThe issue is this is like nicking an engine oil tube to decrease the car mileage. In principle it could work but you really need to nick the right tube at the right place. We have been nicking things everywhere for decades but finally with glp-1 and sglt2 inhibitors we found the right ones. A bit serendipitously.
- jimbob45 3y ago[flagged]
- syndicatedjelly 3y agoWow who is this committee scrutinizing which diseases should be cured based on the race that it most affects?
- Scoundreller 3y agodonors
- mortureb 3y agoFunding
- DoreenMichele 3y agoIt's not a cure and I think the idea is more like "It's an extremely expensive disease and a tiny number of people get it and if it weren't a predominantly Caucasian disorder, no one would be okay with spending this kind of money on it."
- JumpCrisscross 3y ago> if it weren't a predominantly Caucasian disorder, no one would be okay with spending this kind of money on it It has nothing to do with race and everything with money. When ebola came to America, we didn’t find a vaccine because it was infecting white people. We funded it because it was impacting Americans.
- DoreenMichele 3y agoThat's not going to stop some people from saying "The white people are throwing money at this because it's a Caucasian condition." Historically, male diseases got studied more than female diseases, probably having nothing to do with sexism per se. Most physicians and researchers were male, so they were interested in things relevant to their lives. But that doesn't stop people from crying "Sexism!" about it.
- JumpCrisscross 3y ago
- dghughes 3y ago> because it’s basically a white people disease White and mostly male. My local university or more precisely certain students wanted to drop CF as a cause to support due to those factors. Pretty disgusting and it was quickly dismissed for what it was. The uni still supports and fund-raises for a CF cure.
- samus 3y agoCF has a higher incidence in populations of northern European descent, but there is no gender gap there. There is only a so-far unexplained difference in life expectancy that reduces the life expectancy of females surviving to adulthood, which creates the impression that this it mostly affects males.
- odiroot 3y ago> CF makes you not process food correctly so you can eat a ton of food and not gain weight. Is it just quickly extracted as stool?
- samus 3y agoIt occurs less often in other ethnic groups, but not rarely enough that the therapy should be considered irrelevant for them. The f***ked up part is that Trikafta's producer does not make it available to developing countries and tries to block generic alternatives.
- deleted 3y ago[deleted]
- ftxbro 3y agoIn the near or medium future they will screen/crispr the germline so no one will ever have it. Yes it's eugenics but it will happen. Edit: the ones downvoting me is it because you don't think it will happen, or because you don't think it's eugenics, or you think it's rude to talk about it?
- deleted 3y ago[deleted]
- deleted 3y ago[deleted]
- the__alchemist 3y agoConcur. I think this is likely to be controversial, and become an increasingly popular news topic and political wedge. (Maybe in the next few decades?) It seems that we can eliminate some genetic diseases through a combination of screening and embryo selection.
- thedailymail 3y agoThis has already happened with Down syndrome in Denmark. https://cphpost.dk/2020-08-21/news/record-low-numbers-of-children-with-down-syndrome-being-born/ https://cphpost.dk/2020-08-21/news/record-low-numbers-of-chi...
- rcme 3y agoIn the US, when we had a kid, we had genetic screens done for over a hundred genetic diseases. The baby’s DNA was also tested for Down’s.
- karaokeyoga 3y agoSame here, for our second child, since her mother had moved into a higher-risk age category by then. This was in San Francisco in 2005.
- Scoundreller 3y ago
- car 3y agoThe high prevalence of CF in the white population was hypothesized to be due to the protective effect of being a carrier (heterozygous) of a CFTR mutation against typhoid fever, very common in Europe in the old ages. A study in 1997 was able to prove this [0]. [0] https://pubmed.ncbi.nlm.nih.gov/9590693/ https://pubmed.ncbi.nlm.nih.gov/9590693/
- bdcravens 3y agoCholera as well.
- car 3y agoThank you! I forgot about that. This was researched as early as 1994 [0] [0] "Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model", https://pubmed.ncbi.nlm.nih.gov/7524148/ https://pubmed.ncbi.nlm.nih.gov/7524148/
- tastyfreeze 3y agoInteresting. Similar story with sickle cell anemia, more common in Africa, and malaria.
- 0600-885310 3y ago[flagged]
- Selfcommit 3y agoI lost 2 uncles that I loved, and 1 aunt I never met to CF. I am incredibly happy for those who have gained literal decades of life from this new treatment. I do wish the wheel of progress could have moved faster.
- varjag 3y agoMy sympathies. I lost my dearest friend to CF just last year. If it only been developed a few years earlier…
- gustavus 3y agoMy wife has several family members with CF. They have started on trifekta and it has changed their lives radically to the point the disease barely effects them day to day. It truly is a miracle and a breakthrough, and the only shame is that these brave pioneers are only getting $3 million for their heroic efforts. Meanwhile the actual cost of the medicine is $10k a dose.
- bdcravens 3y agoThe pricing is more like $25-30K/month. It's taken twice a day, in pill form. (I have CF and take Trikafta)
- squeaky-clean 3y agoPlease tell me insurance pays for most of that?
- bdcravens 3y agoOf course :-) Vertex's copay assistance is also very generous, even for those with high income. I have a good developer income, and pay essentially nothing.
- trollian 3y agoNot having to deal with insurance & copay shenanigans for my daughter's CF meds is one of the things that keeps me at the large tech company I work at...
- amluto 3y agoI personally consider copay assistance to be essentially fraudulent as a concept. The drug company is literally paying the patient to invoke an insurance benefit that kicks a bunch of money to the drug company. I imagine that when an auto body shop pays their customers’ deductibles, it is fraud, legally and ethically.
- Aurornis 3y ago
- junon 3y agoMy close friend died a few years back from CF. Great to see progress in this area.
- bawolff 3y agoShame the life saving drug is rediculously expensive. I dont normally subscribe to bug pharma being greedy, but this one seems like a compelling case for that. The canadian gov (PMPRB) tried to do sonething about that but i think they backed down
- BurningFrog 3y agoIt's better to think of it as math. Developing drugs is very expensive, and the few that turn out to be effective need to be priced to pay for all those costs. The alternative is pretty much to not develop new drugs.
- maxerickson 3y agoA foundation provided $150 million to develop one of the drugs in the combination and then sold the royalty rights to it for $3.3 billion: https://web.archive.org/web/20141227030211/http://www.cff.org/aboutCFFoundation/PressRoom/PressReleases/PressReleaseArchive/11-19-Transformational-Royalty-Sale.cfm https://web.archive.org/web/20141227030211/http://www.cff.or... https://en.wikipedia.org/wiki/Ivacaftor#Economics https://en.wikipedia.org/wiki/Ivacaftor#Economics Hard to argue that the $3.15 billion is a development cost. I guess Vertex could have dumped billions more into making and marketing the combination.
- BurningFrog 3y agoSure, this drug ends up being profitable. But most of them also cost $150M to develop while making $0. As a whole, I don't think the pharmacy industry is unusually profitable.
- ddeck 3y agoPerhaps not unusually, but there is some evidence that they are more profitable than comparably sized non-pharma companies. >"from 2000 to 2018, the median net income (earnings) expressed as a fraction of revenue was significantly greater for pharmaceutical companies compared with nonpharmaceutical companies (13.8% vs 7.7%)." Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054843/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054843/
- gcanyon 3y agoHow long until we stop noticing that medicine is advancing at warp speed?
- mortureb 3y agoProbably once they cure HIV
- JumpCrisscross 3y ago> once they cure HIV HIV is practically (i.e. not literally) cured, between treatments and PrEP, in the developed world. And it looks like we’re approaching vaccine.
- mortureb 3y agoIt’s practically cured but people are still susceptible to lots of opportunistic infections and have a drastically increased risk of cancer on the medication so it’s really a stopgap.
- snvzz 3y agoOnce we effectively deal with aging, and get to see 120+ yo people in 30s-like overall condition (and indistinguishable at a glance). Aging in characterized in some 8 or 9 ways an old person is different from a young one. Each can be targeted and reverted, in a maintenance approach. Research organized by Aubrey de Grey is all about that.
- gcanyon 3y agoI'm hoping to be one of those 120+ year olds...
- bdcravens 3y agoI have CF, and I take Trikafta. Before Trikafta, I usually had a 5+ day stay in the hospital every year, and sometimes I have would very stubborn respiratory infections that just wouldn't go away. I was mentally preparing myself for inevitable decline and eventual death. Trikafta changed my situation dramatically. I've had no hospitalizations, and most the classic CF symptoms are either gone or extremely diminished. It can't undo a life of damage to things like my pancreas, vas deferens, etc, and I still take medicine to digest my food, but overall, it's as close to "normal" as I could hope for at this point. The only real downside: weight gain. With CF the pancreas is blocked, so you lack in digestive enzymes, and it's a struggle to maintain a healthy enough weight to battle respiratory infections. After Trikafta, I gained some 30 pounds, and have a big belly on my small frame, and went up some 6 inches in the waist. To add insult to injury, it happened during the spring and summer of 2020, when buying clothes was a challenge due to the pandemic. Speaking of the pandemic, the timing of Trikafta was amazing: it kept the normally full "CF floors" of hospitals empty, opening up those beds for those with COVID and keeping CF patients less exposed. One side effect I should mention: many report extreme anxiety. However, I was starting an anxiety medication for the first time (something I should have done 20 years ago, but alas ...) and so those effects were muted or hidden to me.
- az226 3y agoWhat medicine do you take to digest your food? Can you tolerate onions, garlic, and wheat?
- bdcravens 3y agoDigestive enzymes, extracted from pigs. CF has no bearing on what I can tolerate, though the fattier the food, the more difficult it is to digest. In a situation where I had no access to my medication, I'd focus on eating simple carbs, like fruit.
- DoreenMichele 3y agoWell, my understanding is you are simply born without a vas deferens (for most men with CF). But some of the other stuff may heal at least partially.
- drgo 3y agoterrible name though. it won't be taken seriously in Arabic-speaking world where kafta means meatball.
- Scoundreller 3y agodo arabic speakers dislike meatballs? I like meatballs.
- drgo 3y agoI like meatballs just not in a pill form
- DoreenMichele 3y agoIt's a predominantly Caucasian disease, but if they ever find an Arabic market for it they could do name localization. In French, they call CF mucoviscidose which is actually a more medically accurate name. (Shrug)
- refurb 3y agoIt truly is remarkable, not only for the vast improvement in outcome for patients, but also the science. The genetic defect that causes CF results in a chloride channel receptor being malformed so it it doesn't function correctly. The fact they were able to develop a small molecule that perfectly fits within the defective receptor and then causes the receptor to change conformation so that it's now functional is absolutely remarkable. Then layer on top the company has developed a few molecules that can address the different defects in different patients is really amazing science. It's transformed a disease where patients die in their 30's or undergo a risky lung transplant (and still suffer other aspects of the disease after) to a more moderate, treatable disease where life span is normal is one of the great medical achievements of our lifetime.
- mlhpdx 3y agoAt $25k per month per person that’s $30,000,000,000 per year for the 100,000 folks with CF. As a T1D I get it, but there is no way of escaping the other impactful uses of that sum.
- spondylosaurus 3y agoHow much of that $30b is true cost (R&D/manufacturing/distribution) versus cost + profit? Cuz I'm guessing a lot of it is profit. The actual sum of money required to keep those 100k people alive is likely much much much smaller.
- konschubert 3y agoIt’s basically a posterior grant, a price paid out to the company who invented the drug. Eventually the patent will expire and the drug will become cheap for society. In the meantime, the high payout will encourage the development of treatments for other rare diseases
- brigadier132 3y agoAre you arguing for eugenics?
- benzini 3y agoI have CF and I was fortunate enough to qualify for Trikafta despite one of my protein mutations not responding to the drug. I have seen some great quality of life improvements from Trikafta like being able to go to the gym again, not being as winded climbing stairs, gaining weight, and having fewer lung infections. However, Trikafta can't reverse the years of damage from CF, inflammation, and heavy antibiotics to combat nasty infections. I do experience some anxiety and mood swings and have developed recurring kidney stones since starting it. Still, I am thankful that such a drug is available to me and many others like me. Maybe one day CFers will never understand what it means to have advanced lung disease.
- steve_adams_86 3y agoWow, to think that recurring kidney stones are better than what you were experiencing before. That’s incredible. Regardless, I’m glad you’re doing better.
- olliej 3y agoSo this is a $300k/year medication but is apparently just (per the article) a combination of existing approved and developed drugs? As in the cost of development for this seems largely to be covered by the cost of development for the original drugs? Is this behavior something that should be rewarded? “Yay you found you could combine existing drugs to make something better but your charging as much as if you developed those drugs as well”?
- InSteady 3y agoYour cynicism might evaporate if you read the article carefully without jumping to conclusions and make an effort to understand some background of CF: >“There was a lot of scepticism that this could be done,” Hadida recalls. ... The drug-discovery process required a marathon effort, testing the effects of more than one million compounds on isolated human lung cells to identify candidate drugs for clinical trials. All of this research into these drugs was for the purpose of treating CF. They aren't developing drugs that target a CF-related protein in lung tissue to treat any other disorder. These drugs do not work on their own to any meaningful degree because protein function in the immune system is freaking complex. Retraining proteins that are dysfunctional due to a genetic defect is not trivial stuff. They found a combo of drugs that allow a misfolding protein to function properly; two that when combined deliver the protein to the cell surface and then a third to get it to work properly once it is manipulated into the correct place. CF also only effects a tiny percentage of the population. The only way the economics of this research makes sense is if they charge insurers a high price for it. If we don't reward this behavior, 70,000 people worldwide die at age 35 after having a medically miserable life. Instead they now have stunningly high chance of living until age 80 with significant quality of life improvement.
- botanical 3y ago> Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit. > The company is not trying to sell it, or allowing a local company to make it. Vertex is blocking potential generic competitors by seeking patents in numerous countries. https://www.nytimes.com/2023/02/07/health/cystic-fibrosis-drug-trikafta.html https://www.nytimes.com/2023/02/07/health/cystic-fibrosis-dr... https://www.news24.com/you/news/local/this-johannesburg-woman-needs-trikafta-to-treat-her-cystic-fibrosis-and-shes-taking-on-a-us-medical-drug-giant-to-get-it-in-sa-20230320 https://www.news24.com/you/news/local/this-johannesburg-woma... Not to mention the price of $322 000 a year.
- heywhatupboys 3y agohow would you incentivize medicine discovery if not for commercial applications? not like communist countries are well known for groundbreaking new medicine...
- saberience 3y agoIt's easy to say that when it doesn't affect you but I had a childhood friend die last year from CF because he couldn't afford the medical treatments. He was using the various "public funding" sites to raise money but in the end it wasn't enough and he died. I don't know what the solution is as it's a complex issue... but seeing someone young (in their 30s) die from something preventable because they can't afford the drug is perhaps one of the most horrifying and dystopian things I've seen in my life and makes me worried for our future. One presumably where the rich can live 50 years longer than the "poors".
- amrocha 3y agoThe incentive is saving lives. That's what the researchers are in it for. The research is in large part publicly funded. Pharmaceutical companies are just charging rent on top of the discoveries. The best argument you can make is that private pharma competes to improve manufacturing processes, but you world also have that in a 100% public system from multiple countries competing/collaborating with each other.
- vecinu 3y agoA friend works at Vertex and couldn't tell me for the longest time what the secret sauce was. The FDA approval was the only thing blocking their right to basically print money. It's awesome people are benefiting from the drug, even if the money extraction schemes are dubious or marginally ethically ok.
- JumpCrisscross 3y ago$3mm for curing a disease? This is fuck-you money material. The researchers should each get $100mm, to spend on themselves or further research.
- j7ake 3y agoSometimes there’s talk about how science has stalled and there is no progress. It’s nice to be reminded that there has been indeed real progress, especially at the applied and medical sciences.
- customizable 3y agoBill Williams [1], perhaps best known for his 1983 game Alley Cat had CF, and suffered greatly because of the disease. He was 37 when he died. His book "Naked Before God: The Return of a Broken Disciple" is about his experience with CF and his faith. The Digital Antiquarian has a well written article about Bill Williams' life [2]. 1- https://en.wikipedia.org/wiki/Bill_Williams_(game_designer) https://en.wikipedia.org/wiki/Bill_Williams_(game_designer) 2- https://www.filfre.net/2016/01/bill-williams-the-story-of-a-life/ https://www.filfre.net/2016/01/bill-williams-the-story-of-a-...
- bjornsing 3y agoSeems the Swedish government thinks Trikafta is too expensive, so it’s not available/subsidized in Sweden [1]. Must feel terrible to pay 70% taxes and being denied access to a drug that could save your life… :/ 1. https://www.dagensmedicin.se/specialistomraden/luftvagarna/darfor-blir-det-nytt-nej-for-banbrytande-behandling-mot-cystisk-fibros/ https://www.dagensmedicin.se/specialistomraden/luftvagarna/d...
- jamesblonde 3y agoIt is available now. Vertex tried to play off different municipalities against each other, hence the delay.
- poxwole 3y agoWonderful but they are actively working to block third world countries from making generic alternative or providing the drug at a cheaper cost.